JP2009515872A5 - - Google Patents

Download PDF

Info

Publication number
JP2009515872A5
JP2009515872A5 JP2008539670A JP2008539670A JP2009515872A5 JP 2009515872 A5 JP2009515872 A5 JP 2009515872A5 JP 2008539670 A JP2008539670 A JP 2008539670A JP 2008539670 A JP2008539670 A JP 2008539670A JP 2009515872 A5 JP2009515872 A5 JP 2009515872A5
Authority
JP
Japan
Prior art keywords
group
substituted
lower alkoxy
phenyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008539670A
Other languages
English (en)
Japanese (ja)
Other versions
JP5305914B2 (ja
JP2009515872A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2008539670A priority Critical patent/JP5305914B2/ja
Priority claimed from PCT/JP2006/323066 external-priority patent/WO2007058338A2/en
Publication of JP2009515872A publication Critical patent/JP2009515872A/ja
Publication of JP2009515872A5 publication Critical patent/JP2009515872A5/ja
Application granted granted Critical
Publication of JP5305914B2 publication Critical patent/JP5305914B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008539670A 2005-11-15 2006-11-14 オキサゾール化合物及び医薬組成物 Active JP5305914B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008539670A JP5305914B2 (ja) 2005-11-15 2006-11-14 オキサゾール化合物及び医薬組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005330590 2005-11-15
JP2005330590 2005-11-15
PCT/JP2006/323066 WO2007058338A2 (en) 2005-11-15 2006-11-14 Oxazole compound and pharmaceutical composition
JP2008539670A JP5305914B2 (ja) 2005-11-15 2006-11-14 オキサゾール化合物及び医薬組成物

Publications (3)

Publication Number Publication Date
JP2009515872A JP2009515872A (ja) 2009-04-16
JP2009515872A5 true JP2009515872A5 (https=) 2012-02-23
JP5305914B2 JP5305914B2 (ja) 2013-10-02

Family

ID=37879936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008539670A Active JP5305914B2 (ja) 2005-11-15 2006-11-14 オキサゾール化合物及び医薬組成物

Country Status (22)

Country Link
US (9) USRE46792E1 (https=)
EP (1) EP1954684B1 (https=)
JP (1) JP5305914B2 (https=)
KR (1) KR101439557B1 (https=)
CN (1) CN101309912B (https=)
AR (3) AR057891A1 (https=)
AU (1) AU2006316079B2 (https=)
BR (1) BRPI0618589B8 (https=)
CA (1) CA2627541C (https=)
CY (1) CY1115302T1 (https=)
DK (1) DK1954684T3 (https=)
ES (1) ES2483992T3 (https=)
IL (1) IL191008A (https=)
MY (1) MY153720A (https=)
NO (1) NO341440B1 (https=)
PL (1) PL1954684T3 (https=)
PT (1) PT1954684E (https=)
RU (1) RU2418793C2 (https=)
SI (1) SI1954684T1 (https=)
TW (1) TWI330639B (https=)
WO (1) WO2007058338A2 (https=)
ZA (1) ZA200803758B (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4986927B2 (ja) * 2007-05-14 2012-07-25 大塚製薬株式会社 医薬
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
MX2010014066A (es) 2008-06-16 2011-06-01 Univ Tennessee Res Foundation Compuestos para el tratamiento del cancer.
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
GB2465890A (en) * 2008-12-05 2010-06-09 Scynexis Inc 2-Arylazole derivatives as antiprotozoal agents
JP5879273B2 (ja) 2010-03-01 2016-03-08 ジーティーエックス・インコーポレイテッド 癌を処置するための化合物
EP2542089B1 (en) 2010-03-05 2017-01-18 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
KR101713453B1 (ko) * 2010-03-12 2017-03-07 오메로스 코포레이션 Pde10 억제제 및 관련 조성물 및 방법
EP2665362B1 (en) 2011-01-17 2016-03-30 Karyopharm Therapeutics, Inc. Olefin containing nuclear transport modulators and uses thereof
JP6006794B2 (ja) 2011-07-29 2016-10-12 カリオファーム セラピューティクス,インコーポレイテッド 核内輸送調節因子およびその使用
EP4234545A3 (en) 2011-07-29 2023-09-06 Karyopharm Therapeutics Inc. Hydrazide containing nuclear transport modulators and uses thereof
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
CN104080770A (zh) 2011-11-09 2014-10-01 迈兰实验室有限公司 用于制备罗氟司特的改进方法
WO2013170068A2 (en) 2012-05-09 2013-11-14 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
EP2890686B1 (en) 2012-08-30 2017-01-04 Otsuka Pharmaceutical Co., Ltd. Method for producing oxazole compound
EP2968278B8 (en) 2013-03-15 2019-05-22 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
ME03421B (me) 2013-06-21 2020-01-20 Karyopharm Therapeutics Inc 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba
CN105085428B (zh) * 2014-04-25 2019-03-22 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
NZ630803A (en) 2014-04-28 2016-03-31 Omeros Corp Optically active pde10 inhibitor
NZ716494A (en) 2014-04-28 2017-07-28 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
KR102608259B1 (ko) 2014-08-15 2023-11-29 카리오팜 쎄라퓨틱스, 인코포레이티드 셀리넥소의 다형태
TWI689497B (zh) * 2014-09-04 2020-04-01 南北兄弟藥業投資有限公司 芳雜環類衍生物及其在藥物中的應用
KR20170139074A (ko) 2015-04-24 2017-12-18 오메로스 코포레이션 Pde10 억제제 및 관련 조성물 및 방법
CN106188027B (zh) * 2015-09-02 2020-10-20 广东东阳光药业有限公司 芳杂环类衍生物及其在药物中的应用
WO2017079678A1 (en) 2015-11-04 2017-05-11 Omeros Corporation Solid state forms of a pde10 inhibitor
TWI726027B (zh) 2015-12-28 2021-05-01 日商大塚製藥股份有限公司 軟膏
CN106279138B (zh) * 2015-12-29 2019-03-01 广东东阳光药业有限公司 芳杂环类衍生物及其在药物中的应用
EP3397634A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
US10526295B2 (en) 2015-12-31 2020-01-07 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy
PL3774745T3 (pl) * 2018-04-04 2024-08-19 Otsuka Pharmaceutical Co., Ltd. Kryształ cząsteczki oksazolu
CN116194451B (zh) * 2020-11-27 2025-07-11 瑞石生物医药有限公司 芳基或杂芳基取代五元芳杂环化合物及其用途
CN112425610A (zh) * 2021-01-22 2021-03-02 深圳市洛奇机电科技有限公司 一种防治君子兰叶斑病的农药悬浮剂的制备系统及其应用
TW202400154A (zh) 2022-03-25 2024-01-01 日商大塚製藥股份有限公司 創傷治療用組合物
CN115785014B (zh) * 2022-12-27 2025-01-24 瑞石生物医药有限公司 四唑衍生物及其用途
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy
JP7712737B1 (ja) 2024-05-29 2025-07-24 大塚製薬株式会社 オキサゾール化合物含有組成物
CN119798183B (zh) * 2024-12-19 2026-03-24 上海药坦药物研究开发有限公司 一种噁唑类化合物的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735961A (en) 1984-05-07 1988-04-05 Merck & Co., Inc. Oxazoles and thiazoles containing an aminohydroxypropoxyphenyl moiety
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
US20020169173A1 (en) 1993-11-08 2002-11-14 Smithkline Beecham Corporation Oxazoles for treating cytokine mediated diseases
CA2193725A1 (en) * 1994-06-24 1996-01-04 David Cavalla Aryl derivative compounds and uses to inhibit phosphodiesterase iv acti vity
AUPO156596A0 (en) 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
DE19632549A1 (de) 1996-08-13 1998-02-19 Merck Patent Gmbh Arylalkanoylpyridazine
AU4015497A (en) 1996-08-26 1998-03-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazole derivatives useful as selective inhibitors of pde-iv
DE69722258T2 (de) 1996-10-07 2004-03-18 Eli Lilly And Co., Indianapolis Neue verbindungen nutlich als neuroschützende mittel
US6020339A (en) 1997-10-03 2000-02-01 Merck & Co., Inc. Aryl furan derivatives as PDE IV inhibitors
JP4518587B2 (ja) 1998-03-09 2010-08-04 興和創薬株式会社 2−フェニルモルホリン誘導体
AR036237A1 (es) * 2001-07-27 2004-08-25 Bayer Corp Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento
IL161317A0 (en) 2001-10-16 2004-09-27 Memory Pharm Corp 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
US7259175B2 (en) 2002-02-25 2007-08-21 Eli Lilly And Company Peroxisome proliferator activated receptor modulators
JP2004203871A (ja) * 2002-12-13 2004-07-22 Yamanouchi Pharmaceut Co Ltd 医薬組成物
TW200505913A (en) 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
AU2005243384A1 (en) 2004-05-17 2005-11-24 Otsuka Pharmaceutical Co., Ltd. Thiazole compound and use thereof
CA2575081C (en) 2004-07-26 2013-05-07 Eli Lilly And Company Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
DE102004051277A1 (de) 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
CA2602336A1 (en) * 2005-03-31 2006-10-05 Ucb Pharma S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses

Similar Documents

Publication Publication Date Title
JP2009515872A5 (https=)
JP2010510976A5 (https=)
JP2010504286A5 (https=)
JP2007508359A5 (https=)
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
JP2008510828A5 (https=)
WO2008111441A1 (ja) 医薬組成物
JP2009263394A5 (https=)
RU2007139453A (ru) Гетеробициклические ингибиторы вируса гепатита с (hcv)
JP2005289914A5 (https=)
JP2009523146A5 (https=)
JP2005053931A5 (https=)
JP2004521124A5 (https=)
EA200601235A1 (ru) Производные тиазола
JP2012526842A5 (https=)
JP2014524441A5 (https=)
JP2009526868A5 (https=)
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
JP2005517008A5 (https=)
JP2006508979A5 (https=)
JP2010535706A5 (https=)
BRPI0506927A (pt) compostos orgánicos
EP1849788A8 (en) Organosilicon compound
JP2012509262A5 (https=)
RU2004131879A (ru) Ингибитор фосфодиэстеразы iv, содержащий пиридилакриламидное производное